To include your compound in the COVID-19 Resource Center, submit it here.

OrbiMed closes new Asia fund with $325M

OrbiMed Advisors closed its second Asia fund with $325 million, above the firm's $300 million target.

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE